Cargando…

Progressive multifocal leukoencephalopathy in the background of chlorambucil treated chronic lymphocytic leukemia: a case report from Nepal

INTRODUCTION: Progressive multifocal leukoencephalopathy is a rare manifestation in itself. Although many immunosuppressive states are associated with the disease, its occurrence in the setting of chronic lymphocytic leukaemia treated with chemotherapy is seldom reported to date. CASE PRESENTATION:...

Descripción completa

Detalles Bibliográficos
Autores principales: Dhakal, Bishal, Upadhaya Regmi, Binit, Subedi, Ram Chandra, Joshi, Sushil, Pathak, Bishnu Deep, Bogati, Kanchan, Baniya, Sunil, Neupane, Peter, Paudel, Raju
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10553170/
https://www.ncbi.nlm.nih.gov/pubmed/37811014
http://dx.doi.org/10.1097/MS9.0000000000001190
Descripción
Sumario:INTRODUCTION: Progressive multifocal leukoencephalopathy is a rare manifestation in itself. Although many immunosuppressive states are associated with the disease, its occurrence in the setting of chronic lymphocytic leukaemia treated with chemotherapy is seldom reported to date. CASE PRESENTATION: A 67-year-old woman with known chronic lymphocytic leukaemia who was previously receiving chlorambucil treatment was identified as having progressive multifocal leukoencephalopathy; her prognosis is currently good. CLINICAL DISCUSSION: Although a rare disease in an immunocompromised setting, progressive multifocal leukoencephalopathy often leads to a grave outcome. However, the authors describe a case with a good prognosis to date. CONCLUSION: Progressive multifocal leukoencephalopathy should be in differentials in immunocompromised patients with dementia. Given that the later prognosis of the disease is unpredictable, an earlier diagnosis would be better for immunological reconstitution.